SA国际传媒

Investment into biotech and health care boomed during the pandemic as thousands of venture capital firms turned their attention to breakthrough artificial intelligence, cancer-detection technology, mental health treatments, digital doctor visits, diagnostics and more.聽

But two of those investment firms have emerged as major leaders, not only in the number of biotech funding rounds led, but also in overall dollars invested into the industry. Boston-based and New York-based ranked first and second, respectively, on the two lists compiled using SA国际传媒 data.聽

Although the two firms emerged as leaders in the data, they still make up a small part of the more than $120 billion in venture capital funds globally that poured into health and biotech startups as of Dec. 1 this year, SA国际传媒 data shows.聽

While health and biotech are often almost inextricably linked, it鈥檚 worth noting that of that investment, a significant portion is heading directly to companies that place themselves specifically in the biotechnology category.

Here is a breakdown of some of those leaders, based on SA国际传媒 data.聽

Most investment rounds led in biotech聽

Leading a funding round is a big undertaking. The lead investor often acts as the liaison between the startup鈥檚 founder(s) and the other participating investors, or is implicitly trusted by other investors to find the best terms for everyone.聽

These VC firms led the most funding rounds for biotech startups this year between Jan. 1 and Dec. 1, according to SA国际传媒 data. This data also illustrates the total number of biotech industry investment rounds each lead investor participated in during that time, including those rounds the firm led and those it let others lead.聽

Most money invested in biotech startups聽

RA Capital Management and OrbiMed led the way in both total dollars invested and the number of venture capital funding rounds led in the biotech industry last year鈥攖he only two firms to make it onto both lists.聽

Among RA Capital and OrbiMed鈥檚 big bets this year was , which conducts research and development of pharmaceuticals related to COVID-19.聽

RA Capital led the company鈥檚 $336 million Series C ahead of the company鈥檚 August IPO, though the firm hadn鈥檛 participated in the company鈥檚 earlier funding rounds. OrbiMed and , however, participated in Adagio鈥檚 Series A, B and C rounds.聽

To learn more about these VC firms and their 2021 investments take a look at their SA国际传媒 profiles:聽

Illustration: